succinobucol
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Succinobucol (succinyl ester of probucol) is a lipid-lowering compound with anti-inflammatory and antioxidant properties. Recent…
Nearly 285 million people worldwide, with 10% being Americans, suffer from diabetes mellitus and its associated comorbidities…
The aim of this study was to assess the efficacy of stent‐based delivery of succinobucol alone and in combination with rapamycin…
Four different polymorphs, A, C, D, and E, of succinobucol were isolated and characterized by means of solid-state nuclear…
Succinobucol is a derivative of probucol with improved partitioning into cells and potent extracellular antioxidant activity. It…
Synthesis, detailed structural characterization (X-ray, NMR, MS, IR, elemental analysis), and studies of toxicity, antioxidant…
It is now well accepted that a chronic, low-grade inflammation is observed in abdominal obesity, insulin resistance and type 2…
Background: Succinobucol (AGI-1067) was developed as a probucol derivative with anti-inflammatory and antioxidant properties. It…
BACKGROUND
Succinobucol (AGI-1067) was developed as a probucol derivative with anti-inflammatory and antioxidant properties. It…